Rethinking Cancer Care Through the Lens of Immune Intelligence: Free Live Webinar

We regularly share patient stories and practical tools to help you navigate metabolic health and cancer with greater clarity and confidence. To receive MTIH Updates In Your Inbox, CLICK HERE.

What if the key to transforming cancer care lies not in fighting the body, but in helping it remember what it already knows?

That’s the guiding vision behind Immunocine, a pioneering biotech company redefining how we think about immunotherapy. Their approach starts with the body’s own intelligence — harnessing dendritic cells, the “generals” of the immune system, to retrain the immune response and help the body recognize and target cancer cells with precision.

Unlike conventional one-size-fits-all therapies, Immunocine’s platform is fully personalized, created from each patient’s own tumor and immune cells. By “double loading” dendritic cells with matched Class I and II antigens, Immunocine’s process reprograms the immune system to mount a powerful Th1 response — activating killer T-cells to seek out and destroy cancer cells that once went unnoticed.

This next-generation therapy has been studied for over 15 years in collaboration with leading U.S. research institutions, with results published in peer-reviewed journals and supported by FDA clinical trials in aggressive cancers like glioblastoma and pancreatic ductal adenocarcinoma.

But Immunocine’s mission extends beyond technology — it’s about restoring hope. Combined with functional medicine and compassionate, integrative care, their approach aims to elevate the entire experience of cancer treatment and redefine the future of oncological tourism by offering science-based, patient-centered innovation.

✨ Join Dr. Nasha Winters and Rafael Gonzalez, Ph.D., for this free educational session exploring:

• The role of dendritic cells in immune recognition

• How immunological “ignorance” allows cancer to thrive undetected

• The breakthrough concept of double loading for optimal immune activation

• Real-world insights from clinical research and ongoing trials

📅 Thursday, October 2
🕕 6:00 p.m. ET
🔗 Click here to register

💡 Can’t attend live? Register to receive the recording after the event.

🌟 Want to meet the Immunocine team in person? Join us at the 2025 Metabolic Health Day Conference, October 9–11 in Tucson or online. Learn more and register at metabolichealthday.life.